Health & bio

Renaissance Pharma daretabart FDA Fast Track for high-risk neuroblastoma

Anti-GD2 antibody. 4/14 announcement. Oncology momentum 4/13–15 window.

Primary sources · 1
Oncology News Central
← View the full 2026-04-13 (Mon) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →